Zivo Bioscience Inc (ZIVO)
Zivo Bioscience, Inc. is a common stock listing on OTC Markets. The company and its subsidiaries focus on licensing and selling natural bioactive ingredients derived from proprietary algae cultures for use by animal, human, dietary supplement, and medical food manufacturers. Its activities span biotech and agtech applications, supported by an intellectual property portfolio that includes proprietary algal and bacterial strains, biologically active compounds, cultivation methods, production techniques, and patented or patent-pending inventions. Zivo Bioscience’s product and ingredient work includes areas such as poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modulation, functional food ingredients, algal biomass for human food, and biomass associated with skin health and anti-aging. The company was previously known as Health Enhancement Products, Inc. and adopted its current name in October 2014. It is headquartered in Troy, Michigan.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-ZIVO
|
$4.48
|
2.3% Upside
|
Fair
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 13, 2026
|
-2.0x
|
-5.2x
|
81.0x
|
16.939 M
|
17.701 M
|
4.6%
|
37.9%
|
-414.0
|
—
|
36.3%
|